Brookfield and Ginkgo Join Prestigious Stock Indices
New York, Monday, 30 June 2025.
As of June 30, 2025, Brookfield Asset Management and Ginkgo Bioworks have been added to significant stock indices, boosting their visibility and potentially attracting new investments.
Brookfield Asset Management’s Strategic Inclusion
Brookfield Asset Management Ltd. (NYSE: BAM) has been officially added to the Russell 1000 Growth Index as of June 30, 2025. This inclusion reflects the company’s robust market performance and growth potential within the large-cap segment [1]. The Russell 1000 Growth Index comprises companies with higher price-to-book ratios and anticipated growth rates, often attracting institutional investment flows. Brookfield’s renewable energy projects, which include a diverse portfolio of wind, solar, and hydroelectric power, account for significant contributions to its growth strategy [3].
Impact on Market Visibility and Investment
Joining the Russell 1000 Growth Index is expected to enhance Brookfield’s visibility among investors by aligning the company with $8.5 trillion in benchmark assets and $2 trillion in passive tracking capital [2]. Such significant inclusion is likely to drive substantial liquidity into the company’s stocks, potentially leading to a surge in trading volume as previously noted in past rebalancing events [3]. Moreover, the company’s commitment to expanding its fee-earning assets from $550 billion to $1.1 trillion by 2030 indicates a relentless ambition for expansive growth [4].
Ginkgo Bioworks’ Growth Trajectory
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a leader in the bioscience field, has joined the Russell 2500 Index, underscoring its position among rapidly growing mid-cap companies [5]. This index inclusion marks a significant milestone in Ginkgo’s journey as it strengthens its foothold in biotechnology with innovative solutions ranging from cell programming to biosecurity services [6]. The Russell 2500 recognizes mid-sized companies that are poised for substantial growth, aligning perfectly with Ginkgo’s technological advancements across health and industrial sectors.
Potential Benefits of Index Inclusions
Both Brookfield and Ginkgo’s additions to their respective indices entail broader exposure to a diverse pool of institutional investors, potentially increasing stock demand and subsequent market valuation [1][5]. Historical data suggest that companies joining major indices tend to experience increased trading liquidity and share price performance due to increased visibility and institutional investor interest [3][6]. As these companies navigate their evolving sectors, their strategic positions in these indices signal confidence in their growth trajectories and market significance.